5 Centrally Acting Dopamine D2 Receptor Ligands: Agonists
- 1 January 1992
- book chapter
- Published by Elsevier in Progress in Medicinal Chemistry
- Vol. 29, 185-216
- https://doi.org/10.1016/s0079-6468(08)70008-0
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Dopaminergic drugs in the cationic form interact with D2 dopamine receptorsTrends in Pharmacological Sciences, 1988
- Structure-activity relationships for apomorphine congeners. Conformational energies vs. biological activitiesJournal of Computer-Aided Molecular Design, 1987
- Computer-aided molecular modeling of a D2-agonist dopamine pharmacophoreJournal of Computer-Aided Molecular Design, 1987
- Drug design via pharmacophore identification. Dopaminergic activity of 3H-benz[e]indol-8-amines and their mode of interaction with the dopamine receptorJournal of Medicinal Chemistry, 1986
- Pharmacological profile of the abeorphine 201–678, a potent orally active and long lasting dopamine agonistLife Sciences, 1986
- Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Dopamine agonist activity of EMD 23,448Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Resolved 3-(3-Hydroxyphenyl)-N-n-propylpiperidine and its analogs: central dopamine receptor activityJournal of Medicinal Chemistry, 1984